Published in Proc Natl Acad Sci U S A on August 05, 1997
The Effects of Reproductive Hormones on Mood and Behavior | NCT00001322
Studies of Frontal Lobe Brain Functioning in Schizophrenia | NCT00001258
Neurotrophic and neuroprotective actions of estrogen: basic mechanisms and clinical implications. Steroids (2007) 2.56
Menstrual cycle phase modulates reward-related neural function in women. Proc Natl Acad Sci U S A (2007) 2.35
Estrogen actions in the brain and the basis for differential action in men and women: a case for sex-specific medicines. Pharmacol Rev (2010) 2.13
Uncovering the mechanisms of estrogen effects on hippocampal function. Front Neuroendocrinol (2007) 2.13
Estrogen shapes dopamine-dependent cognitive processes: implications for women's health. J Neurosci (2011) 1.55
Alterations in brain activation during working memory processing associated with breast cancer and treatment: a prospective functional magnetic resonance imaging study. J Clin Oncol (2012) 1.49
Cognitive performance in healthy women during induced hypogonadism and ovarian steroid addback. Arch Womens Ment Health (2012) 1.45
Variants in the estrogen receptor alpha gene and its mRNA contribute to risk for schizophrenia. Hum Mol Genet (2008) 1.36
Hormone therapy and cognitive function. Hum Reprod Update (2009) 1.22
Sex hormones and mood in the perimenopause. Ann N Y Acad Sci (2009) 1.20
Neuropsychological dysfunction associated with cancer and cancer therapies: a conceptual review of an emerging target. Br J Cancer (2004) 1.15
Risk for premenstrual dysphoric disorder is associated with genetic variation in ESR1, the estrogen receptor alpha gene. Biol Psychiatry (2007) 1.12
Age-related gray matter volume changes in the brain during non-elderly adulthood. Neurobiol Aging (2009) 1.10
Distribution of mRNAs encoding classical progestin receptor, progesterone membrane components 1 and 2, serpine mRNA binding protein 1, and progestin and ADIPOQ receptor family members 7 and 8 in rat forebrain. Neuroscience (2010) 1.08
Progesterone to ovariectomized mice enhances cognitive performance in the spontaneous alternation, object recognition, but not placement, water maze, and contextual and cued conditioned fear tasks. Neurobiol Learn Mem (2008) 1.06
Sex hormones affect neurotransmitters and shape the adult female brain during hormonal transition periods. Front Neurosci (2015) 1.06
Interactive effects of age and estrogen on cortical neurons: implications for cognitive aging. Neuroscience (2011) 1.06
Oestrogen receptor alpha localisation in the prefrontal cortex of three mammalian species. J Neuroendocrinol (2008) 1.04
Endogenous oestrogens predict 4-year decline in verbal fluency in postmenopausal women: the Rancho Bernardo Study. Clin Endocrinol (Oxf) (2009) 1.03
Transdermal estradiol for postpartum depression: a promising treatment option. Clin Obstet Gynecol (2009) 1.01
Mechanisms of action of estrogen in the brain: insights from human neuroimaging and psychopharmacologic studies. Semin Reprod Med (2009) 1.00
Changes in estrogen receptor-alpha mRNA in the mouse cortex during development. Brain Res (2007) 1.00
Influences of menstrual cycle position and sex hormone levels on spontaneous intrusive recollections following emotional stimuli. Conscious Cogn (2011) 1.00
Changes in brain size during the menstrual cycle. PLoS One (2011) 0.98
Effects of gonadectomy and hormone replacement on a spontaneous novel object recognition task in adult male rats. Horm Behav (2008) 0.98
Neural systems supporting cognitive-affective interactions in adolescence: the role of puberty and implications for affective disorders. Front Integr Neurosci (2012) 0.94
Progestogens and estrogen influence impulsive burying and avoidant freezing behavior of naturally cycling and ovariectomized rats. Pharmacol Biochem Behav (2009) 0.94
Neurosteroids' effects and mechanisms for social, cognitive, emotional, and physical functions. Psychoneuroendocrinology (2009) 0.94
Executive function and attention are preserved in older surgically menopausal monkeys receiving estrogen or estrogen plus progesterone. J Neurosci (2009) 0.93
Allopregnanolone as a mediator of affective switching in reproductive mood disorders. Psychopharmacology (Berl) (2014) 0.92
Selective Estrogen Receptor Modulation Increases Hippocampal Activity during Probabilistic Association Learning in Schizophrenia. Neuropsychopharmacology (2015) 0.92
The molecular pathology of schizophrenia--focus on histone and DNA modifications. Brain Res Bull (2009) 0.89
Abnormalities of dorsolateral prefrontal function in women with premenstrual dysphoric disorder: a multimodal neuroimaging study. Am J Psychiatry (2013) 0.89
Sex-dependent diversity in ventral tegmental dopaminergic neurons and developmental programing: A molecular, cellular and behavioral analysis. Neuroscience (2014) 0.87
Functional and molecular neuroimaging of menopause and hormone replacement therapy. Front Neurosci (2014) 0.86
Chemotherapy-induced amenorrhea: a prospective study of brain activation changes and neurocognitive correlates. Brain Imaging Behav (2013) 0.86
Effects of alcohol intoxication and gender on cerebral perfusion: an arterial spin labeling study. Alcohol (2011) 0.86
GABAergic neuroactive steroids and resting-state functional connectivity in postpartum depression: a preliminary study. J Psychiatr Res (2013) 0.86
Evaluation of prefrontal-hippocampal effective connectivity following 24 hours of estrogen infusion: an FDG-PET study. Psychoneuroendocrinology (2008) 0.85
Dysregulation of estrogen receptor beta (ERβ), aromatase (CYP19A1), and ER co-activators in the middle frontal gyrus of autism spectrum disorder subjects. Mol Autism (2014) 0.85
The role of reproductive hormones in postpartum depression. CNS Spectr (2014) 0.84
Sex and gender in psychoneuroimmunology research: past, present and future. Brain Behav Immun (2009) 0.84
Aging, estrogens, and episodic memory in women. Cogn Behav Neurol (2009) 0.83
[18F]2-fluoro-2-deoxy-D-glucose positron emission tomography demonstration of estrogen negative and positive feedback on luteinizing hormone secretion in women. J Clin Endocrinol Metab (2008) 0.80
Clinical epidemiology of premenstrual disorder: informing optimized patient outcomes. Int J Womens Health (2015) 0.79
Ovarian hormones and borderline personality disorder features: Preliminary evidence for interactive effects of estradiol and progesterone. Biol Psychol (2015) 0.79
Cerebrovascular reactivity across the menstrual cycle in young healthy women. Neuroradiol J (2013) 0.79
Depression in women with spontaneous 46, XX primary ovarian insufficiency. J Clin Endocrinol Metab (2010) 0.79
Progesterone can enhance consolidation and/or performance in spatial, object and working memory tasks in Long-Evans rats. Anim Behav (2009) 0.78
Associations between DNA methylation and schizophrenia-related intermediate phenotypes - a gene set enrichment analysis. Prog Neuropsychopharmacol Biol Psychiatry (2015) 0.78
17β-estradiol differentially regulates stress circuitry activity in healthy and depressed women. Neuropsychopharmacology (2014) 0.77
Sex differences in orbitofrontal connectivity in male and female veterans with TBI. Brain Imaging Behav (2015) 0.76
Estrogen receptor alpha (ESR-1) associations with psychological traits in women with PMDD and controls. J Psychiatr Res (2010) 0.76
Longitudinal brain volumetric changes during one year in non-elderly healthy adults: a voxel-based morphometry study. Braz J Med Biol Res (2012) 0.75
Gonadal steroids, brain, and behavior: role of context. Dialogues Clin Neurosci (2002) 0.75
Distinct cognitive effects of estrogen and progesterone in menopausal women. Psychoneuroendocrinology (2015) 0.75
Impact of Sex and Menopausal Status on Episodic Memory Circuitry in Early Midlife. J Neurosci (2016) 0.75
Sex differences in visuospatial abilities persist during induced hypogonadism. Neuropsychologia (2015) 0.75
Functional neuroimaging as a direct probe of the effects of gonadal steroid hormones on the brain. Dialogues Clin Neurosci (2002) 0.75
Hormone therapy at early post-menopause increases cognitive control-related prefrontal activity. Sci Rep (2017) 0.75
The ESC/E(Z) complex, an effector of response to ovarian steroids, manifests an intrinsic difference in cells from women with premenstrual dysphoric disorder. Mol Psychiatry (2017) 0.75
Presynaptic Dopamine Synthesis Capacity in Schizophrenia and Striatal Blood Flow Change During Antipsychotic Treatment and Medication-Free Conditions. Neuropsychopharmacology (2017) 0.75
The steroid metabolome in women with premenstrual dysphoric disorder during GnRH agonist-induced ovarian suppression: effects of estradiol and progesterone addback. Transl Psychiatry (2017) 0.75
An inventory for measuring depression. Arch Gen Psychiatry (1961) 84.61
Rapid automated algorithm for aligning and reslicing PET images. J Comput Assist Tomogr (1992) 6.39
Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. Nature (1995) 5.63
Comparing functional (PET) images: the assessment of significant change. J Cereb Blood Flow Metab (1991) 4.69
Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence. Arch Gen Psychiatry (1986) 4.34
Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. Science (1979) 3.32
Common cortical and subcortical targets of the dorsolateral prefrontal and posterior parietal cortices in the rhesus monkey: evidence for a distributed neural network subserving spatially guided behavior. J Neurosci (1988) 3.00
Relationships among local functional activity, energy metabolism, and blood flow in the central nervous system. Fed Proc (1981) 2.05
The role of D1-dopamine receptor in working memory: local injections of dopamine antagonists into the prefrontal cortex of rhesus monkeys performing an oculomotor delayed-response task. J Neurophysiol (1994) 1.76
Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. III. A new cohort and evidence for a monoaminergic mechanism. Arch Gen Psychiatry (1988) 1.75
Epileptic seizures in women related to plasma estrogen and progesterone during the menstrual cycle. Acta Neurol Scand (1976) 1.68
Physiological activation of a cortical network during performance of the Wisconsin Card Sorting Test: a positron emission tomography study. Neuropsychologia (1995) 1.65
Gonadotropin-releasing hormone and its analogs. Annu Rev Med (1994) 1.61
Convergent pathways for steroid hormone- and neurotransmitter-induced rat sexual behavior. Science (1994) 1.46
Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. II. Role of neuroleptic treatment, attention, and mental effort. Arch Gen Psychiatry (1986) 1.42
Dextroamphetamine enhances "neural network-specific" physiological signals: a positron-emission tomography rCBF study. J Neurosci (1996) 1.18
The effect of amphetamine on regional cerebral blood flow during cognitive activation in schizophrenia. J Neurosci (1991) 1.17
Gender differences in cerebral blood flow as a function of cognitive state with PET. J Nucl Med (1996) 1.11
Sex-dependent behavioral effects of cerebral cortical lesions in the developing rhesus monkey. Science (1974) 1.07
Performance comparison of parameter estimation techniques for the quantitation of local cerebral blood flow by dynamic positron computed tomography. J Cereb Blood Flow Metab (1985) 1.07
The gonad-brain relationship: effects of female sex hormones on electroshock convulsions in the rat. Endocrinology (1962) 1.03
Gonadal hormones influence the emergence of cortical function in nonhuman primates. Behav Neurosci (1989) 1.02
Acute stimulatory effect of estradiol on striatal dopamine synthesis. J Neurochem (1995) 1.01
Neuropsychologic dysfunction in women following leuprolide acetate induction of hypoestrogenism. J Assist Reprod Genet (1993) 0.96
Regional cerebral blood flow during the Wisconsin Card Sorting Test in normal subjects studied by xenon-133 dynamic SPECT: comparison of absolute values, percent distribution values, and covariance analysis. Psychiatry Res (1993) 0.91
Sex differences and effects of estrogen on dopamine and DOPAC release from the striatum of male and female CD-1 mice. Exp Neurol (1994) 0.88
Evaluation of synthetic agonist analogue of gonadotropin-releasing hormone (leuprolide) on testicular androgen production in patients with carcinoma of prostate. Urology (1985) 0.83
Dopaminergic stimulation of estrogen receptor binding in vivo: a reexamination. Recent Prog Horm Res (1994) 0.81
Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A (2001) 9.42
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry (2005) 9.23
Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry (1987) 8.81
Undetectable intracellular free copper: the requirement of a copper chaperone for superoxide dismutase. Science (1999) 6.86
Metal ion chaperone function of the soluble Cu(I) receptor Atx1. Science (1997) 4.55
Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence. Arch Gen Psychiatry (1986) 4.34
Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited. Cereb Cortex (2000) 3.37
Physiological characteristics of capacity constraints in working memory as revealed by functional MRI. Cereb Cortex (1999) 3.31
Anatomical abnormalities in the brains of monozygotic twins discordant for schizophrenia. N Engl J Med (1990) 3.10
Neuropsychological assessment of monozygotic twins discordant for schizophrenia. Arch Gen Psychiatry (1990) 3.07
Dissociation in Pseudomonas aeruginosa. J Bacteriol (1964) 3.00
Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. Proc Natl Acad Sci U S A (1997) 3.00
Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. N Engl J Med (1998) 2.81
Evidence for abnormal cortical functional connectivity during working memory in schizophrenia. Am J Psychiatry (2001) 2.80
Effects of gonadal steroids in women with a history of postpartum depression. Am J Psychiatry (2000) 2.62
Cognitive impairments in patients with schizophrenia displaying preserved and compromised intellect. Arch Gen Psychiatry (2000) 2.62
Noise reduction in 3D perfusion imaging by attenuating the static signal in arterial spin tagging (ASSIST). Magn Reson Med (2000) 2.58
The epidemiology of DSM-III-R bipolar I disorder in a general population survey. Psychol Med (1997) 2.57
Neurophysiological correlates of age-related changes in human motor function. Neurology (2002) 2.52
Auditory working memory and Wisconsin Card Sorting Test performance in schizophrenia. Arch Gen Psychiatry (1997) 2.48
A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity. Biol Psychiatry (2000) 2.32
Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacology (2000) 2.28
Further evidence for dementia of the prefrontal type in schizophrenia? A controlled study of teaching the Wisconsin Card Sorting Test. Arch Gen Psychiatry (1987) 2.24
Impact of complex genetic variation in COMT on human brain function. Mol Psychiatry (2006) 2.22
H(2)(15)O PET validation of steady-state arterial spin tagging cerebral blood flow measurements in humans. Magn Reson Med (2000) 2.20
Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia. Mol Psychiatry (2003) 2.18
Allelic variation in GAD1 (GAD67) is associated with schizophrenia and influences cortical function and gene expression. Mol Psychiatry (2007) 2.12
Histological recovery and gluten-free diet adherence: a prospective 1-year follow-up study of adult patients with coeliac disease. Aliment Pharmacol Ther (2014) 2.09
Relative risk for cognitive impairments in siblings of patients with schizophrenia. Biol Psychiatry (2001) 2.08
Versajet hydrosurgery in burn wound debridement: a preliminary experience. Burns (2007) 2.08
Schizophrenia and temporal lobe epilepsy. A neuropsychological analysis. Arch Gen Psychiatry (1994) 2.07
Relative risk of attention deficits in siblings of patients with schizophrenia. Am J Psychiatry (2000) 2.07
Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A-deficient mice. J Clin Invest (2001) 2.03
Genetic contributions to regional variability in human brain structure: methods and preliminary results. Neuroimage (2002) 2.01
Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage: a potential animal model of schizophrenia. Neuropsychopharmacology (1993) 1.99
Lateral cerebral ventricular enlargement in chronic schizophrenia. Arch Gen Psychiatry (1979) 1.94
Genetic variability of human brain size and cortical gyral patterns. Brain (1997) 1.92
Psychiatric disturbances in metachromatic leukodystrophy. Insights into the neurobiology of psychosis. Arch Neurol (1992) 1.91
Cognitive substrates of thought disorder, I: the semantic system. Am J Psychiatry (1998) 1.90
To model a psychiatric disorder in animals: schizophrenia as a reality test. Neuropsychopharmacology (2000) 1.89
Serotonergic dysfunction, negative mood states, and response to alcohol. Alcohol Clin Exp Res (2001) 1.85
Inhibition of cellular ras prevents smooth muscle cell proliferation after vascular injury in vivo. Nat Med (1995) 1.81
Lack of effect of induced menses on symptoms in women with premenstrual syndrome. N Engl J Med (1991) 1.80
Estrogen replacement in perimenopause-related depression: a preliminary report. Am J Obstet Gynecol (2000) 1.80
Contrasts between patients with affective disorders and patients with schizophrenia on a neuropsychological test battery. Am J Psychiatry (1993) 1.78
The effect of clozapine on cognition and psychiatric symptoms in patients with schizophrenia. Br J Psychiatry (1993) 1.75
Catechol O-methyltransferase mRNA expression in human and rat brain: evidence for a role in cortical neuronal function. Neuroscience (2003) 1.74
Genetic variants in AVPR1A linked to autism predict amygdala activation and personality traits in healthy humans. Mol Psychiatry (2008) 1.70
Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysms. J Clin Microbiol (1996) 1.68
Cannabinoid CB1-receptor mediated regulation of gastrointestinal motility in mice in a model of intestinal inflammation. Br J Pharmacol (2001) 1.67
Evidence of biologic epistasis between BDNF and SLC6A4 and implications for depression. Mol Psychiatry (2008) 1.66
Effects of hydroxymethylglutaryl coenzyme A reductase inhibitor simvastatin on smooth muscle cell proliferation in vitro and neointimal formation in vivo after vascular injury. J Am Coll Cardiol (2000) 1.66
Physiological activation of a cortical network during performance of the Wisconsin Card Sorting Test: a positron emission tomography study. Neuropsychologia (1995) 1.65
Posttransfusion hepatitis after exclusion of commercial and hepatitis-B antigen-positive donors. Ann Intern Med (1972) 1.64
COMT genotype predicts cortical-limbic D1 receptor availability measured with [11C]NNC112 and PET. Mol Psychiatry (2008) 1.63
Elevated S100B levels do not correlate with the severity of encephalopathy during sepsis. Br J Anaesth (2007) 1.63
Effects of dextroamphetamine on cognitive performance and cortical activation. Neuroimage (2000) 1.63
Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophrenia. Mol Psychiatry (2004) 1.62
Correction for vascular artifacts in cerebral blood flow values measured by using arterial spin tagging techniques. Magn Reson Med (1997) 1.61
The relationship between dorsolateral prefrontal N-acetylaspartate measures and striatal dopamine activity in schizophrenia. Biol Psychiatry (1999) 1.60
Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. IV. Further evidence for regional and behavioral specificity. Arch Gen Psychiatry (1988) 1.58
Dehydroepiandrosterone treatment of midlife dysthymia. Biol Psychiatry (1999) 1.57
GAD1 (2q31.1), which encodes glutamic acid decarboxylase (GAD67), is associated with childhood-onset schizophrenia and cortical gray matter volume loss. Mol Psychiatry (2005) 1.56
The neurodevelopmental hypothesis of schizophrenia: following a trail of evidence from cradle to grave. Dev Psychopathol (2000) 1.54
Functional magnetic resonance imaging brain mapping in psychiatry: methodological issues illustrated in a study of working memory in schizophrenia. Neuropsychopharmacology (1998) 1.54
Genetic variation in MAOA modulates ventromedial prefrontal circuitry mediating individual differences in human personality. Mol Psychiatry (2007) 1.54
A proposal to standardize terminology for weak D antigen. Transfusion (1992) 1.52
Selective abnormalities of prefrontal serotonergic receptors in schizophrenia. A postmortem study. Arch Gen Psychiatry (1993) 1.52
Serious obstetric complications interact with hypoxia-regulated/vascular-expression genes to influence schizophrenia risk. Mol Psychiatry (2008) 1.51
Acute depression from isotretinoin. J Am Acad Dermatol (1990) 1.50
Effects of the menstrual cycle on dependent variables in mood disorder research. Arch Gen Psychiatry (1994) 1.50
High-resolution 1H NMR study of the solution structure of alamethicin. Biochemistry (1987) 1.49
Neonatal excitotoxic hippocampal damage in rats causes post-pubertal changes in prepulse inhibition of startle and its disruption by apomorphine. Psychopharmacology (Berl) (1995) 1.48
Is the mechanism of prefrontal hypofunction in depression the same as in schizophrenia? Regional cerebral blood flow during cognitive activation. Br J Psychiatry (1993) 1.47
Catechol-o-methyltransferase enzyme activity and protein expression in human prefrontal cortex across the postnatal lifespan. Cereb Cortex (2006) 1.46
A comparison of rCBF patterns during letter and semantic fluency. Neuropsychology (2000) 1.45
Searching for a consensus five-factor model of the Positive and Negative Syndrome Scale for schizophrenia. Schizophr Res (2012) 1.44
Reported alcohol use in women with premenstrual syndrome. Am J Psychiatry (1994) 1.44
The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells. Ann Intern Med (1987) 1.44
Premenstrual syndromes: overview from a methodologic perspective. Am J Psychiatry (1984) 1.44
Gbetagamma-dependent phosphoinositide 3-kinase activation in hearts with in vivo pressure overload hypertrophy. J Biol Chem (2000) 1.43
Spectrum of atrial septal defects associated with mutations of NKX2.5 and GATA4 transcription factors. J Med Genet (2005) 1.43
Posttransfusion hepatitis after open-heart operations. Incidence after the administration of blood from commercial and volunteer donor populations. JAMA (1970) 1.43
Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. II. Role of neuroleptic treatment, attention, and mental effort. Arch Gen Psychiatry (1986) 1.42
MRI asymmetries of Broca's area: the pars triangularis and pars opercularis. Brain Lang (1998) 1.41
Effect of nicotine on brain activation during performance of a working memory task. Proc Natl Acad Sci U S A (2001) 1.41
Fluvoxamine increases plasma and urinary levels of clozapine and its major metabolites in a time- and dose-dependent manner. J Clin Psychopharmacol (2000) 1.41
A quantitative analysis of smooth pursuit eye tracking in monozygotic twins discordant for schizophrenia. Arch Gen Psychiatry (1997) 1.41
Effective pharmacotherapy of alcoholic amnestic disorder with fluvoxamine. Preliminary findings. Arch Gen Psychiatry (1989) 1.41
Estrogen-serotonin interactions: implications for affective regulation. Biol Psychiatry (1998) 1.40